Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.17 -0.02 (-1.68%)
At close: Oct 23, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Cash & Current Investments (2019 - 2026)

Updated

Alx Oncology Holdings' Cash & Current Investments came in at $138.23 million for Q2 2026, up 74.3% from $79.31 million a year earlier but down 1.5% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Alx Oncology Holdings' Cash & Current Investments was $44.79 million, down 64.9% from FY2024.

  • Cash & Current Investments has declined in each of the last five years, with a five-year compound annual growth rate of -36.5% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $127.76 million in FY2024 (-30.1%), $182.74 million in FY2023 (-31.4%), $266.21 million in FY2022 (-26.8%) and $363.67 million in FY2021 (-16.2%).
  • The five-year range for quarterly Cash & Current Investments is $44.79 million (Q4 2025) to $385.15 million (Q3 2021).
  • Year-over-year, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 18.2%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 74.3%), and the weakest in Q4 2025 (a decline of 64.9%).
  • Business Quant data shows ALXO's Cash & Current Investments at $140.32 million (Q1 2026), $44.79 million (Q4 2025) and $60.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Alx Oncology Holdings 161.71 Mn -222.26 Mn - 138.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.23 Mn
Mar 31, 2026 140.32 Mn
Dec 31, 2025 44.79 Mn
Sep 30, 2025 60.63 Mn
Jun 30, 2025 79.31 Mn
Mar 31, 2025 97.83 Mn
Dec 31, 2024 127.76 Mn
Sep 30, 2024 148.57 Mn
Jun 30, 2024 156.72 Mn
Mar 31, 2024 157.44 Mn
Dec 31, 2023 182.74 Mn
Sep 30, 2023 190.01 Mn
Jun 30, 2023 212.84 Mn
Mar 31, 2023 227.94 Mn
Dec 31, 2022 266.21 Mn
Sep 30, 2022 284.91 Mn
Jun 30, 2022 313.37 Mn
Mar 31, 2022 316.60 Mn
Dec 31, 2021 363.67 Mn
Sep 30, 2021 385.15 Mn
API Access

Alx Oncology Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALXO&period=max&api_key=YOUR_API_KEY